CHAPTER 1 The Food and Drug Administration
Index
- CHAPTER § 1.01 FDA Regulation of Investigational New Drugs
- CHAPTER § 1.02 Clinical Trials Registration and Results Disclosure Requirements
- CHAPTER § 1.03 FDA Approval of New Drug Applications and Supplemental New Drug Applications
- CHAPTER § 1.04 Postmarketing Adverse Events
- CHAPTER § 1.05 Product Recalls
- CHAPTER § 1.06 Violations of FDA's Good Manufacturing Practice Requirements
- CHAPTER § 1.07 FDA's Requirements for Prescription Drug Advertising and Promotion
- CHAPTER § 1.08 Obtaining Admissible Evidence and Testimony from FDA